We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App


31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

New, Simple Clinical Test Detects Rare Life-Threatening Genetic Heart Condition

By HospiMedica International staff writers
Posted on 21 Jun 2024
Print article
Image: The new clinical test detects a life-threatening genetic arrhythmia (Photo courtesy of 123RF)
Image: The new clinical test detects a life-threatening genetic arrhythmia (Photo courtesy of 123RF)

Calcium release deficiency syndrome (CRDS) is a life-threatening genetic arrhythmia that triggers dangerously rapid heartbeats, leading to severe complications like sudden cardiac arrest and death. Often, CRDS goes undetected by standard clinical tests, causing many cardiac arrests to be labeled as unexplained. This lack of detection prevents targeted care from being provided to survivors and at-risk family members. Now, a new, simple clinical test can identify CRDS by observing changes in electrocardiography (ECG) after a short period of rapid heartbeats followed by a pause, which can happen naturally or be induced by pacing the heart artificially.

In 2021, a research team from Hamilton Health Sciences (HHS, Ontario, Canada) confirmed the existence of this rare genetic syndrome. Until now, diagnosing CRDS has required specialized laboratory tests only available in research settings, which are not accessible to most doctors. This limitation has hampered the management and care of affected individuals and their families. In the latest research, an international team of researchers conducted a multi-centre case-control study involving 68 participants across 10 centers in seven countries, including HHS. This study grouped participants into four categories, including those diagnosed with CRDS and survivors of UCA. Additional research involving genetic mouse models has mirrored human findings and offered insights into the cellular mechanisms that produce the ECG signature indicative of CRDS.

This research is the initial phase in developing a diagnostic method for CRDS and gathering more data through the ongoing PHRI DIAGNOSE CRDS trial. This larger international effort aims to strengthen their findings. Currently in its recruitment phase, the DIAGNOSE CRDS trial plans to enroll 500 participants from 30 sites in 10 countries, including HHS. The impact of CRDS has led to numerous tragic events affecting families worldwide. The research team hopes that this simple pacing test will soon be integrated into routine diagnostic evaluations initially for UCAs, offering a new avenue for improving outcomes and preventing future tragedies.

“This novel and simple diagnostic method, which can be performed using an electrocardiogram in a broad range of clinical settings, is hopefully an important step towards improving our evaluation of initially unexplained cardiac arrest (UCA),” said HHS cardiac electrophysiologist Dr. Jason Roberts.

“This is an important discovery because there is an urgent need for a clinical diagnostic test for CRDS,” said Dr. Wayne Chen, a scientist and professor at the Libin Cardiovascular Institute and Hotchkiss Brain Institute at the University of Calgary’s Cumming School of Medicine. “This will allow us to identify individuals at risk, better understand the prevalence of CRDS and, hopefully, develop treatments for the condition.”

Related Links:
Hamilton Health Sciences
University of Calgary

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
12-Channel ECG
Silver Member
Wireless Mobile ECG Recorder
Multi-Parameter Patient Monitor

Print article


Surgical Techniques

view channel
Image: The SIRA RFA electrosurgical device designed specifically for patients undergoing breast-conserving surgery (Photo courtesy of Innoblative Designs)

Novel Electrosurgical Device Could Be a Game-Changer for Breast Cancer Treatment

Breast cancer represents a significant health issue globally, affecting women in every country. After diagnosis, patients face challenging choices about their treatment paths. One common treatment, Breast... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more


view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.